Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Garsorasib |
| Trade Name | |
| Synonyms | D1553|D 1553|D-1553 |
| Drug Descriptions |
Garsorasib (D-1553) inhibits KRAS G12C, which potentially results in decreased tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 932, PMID: 36948246). |
| DrugClasses | KRAS G12C inhibitor 36 |
| CAS Registry Number | 2559761-14-5 |
| NCIT ID | C178562 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BI 853520 + Garsorasib | BI 853520 Garsorasib | 0 | 0 |
| Carboplatin + Garsorasib | Carboplatin Garsorasib | 0 | 0 |
| Cetuximab + Garsorasib | Cetuximab Garsorasib | 0 | 0 |
| Cisplatin + Garsorasib | Cisplatin Garsorasib | 0 | 0 |
| Garsorasib | Garsorasib | 0 | 1 |
| Garsorasib + Oxaliplatin | Garsorasib Oxaliplatin | 0 | 0 |
| Garsorasib + RMC-4550 | Garsorasib RMC-4550 | 0 | 0 |
| Garsorasib + Trametinib | Garsorasib Trametinib | 0 | 0 |